Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
FOLD
FOLD
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest FOLD ETF News Today | Earnings, Events & Price Alerts
FOLD News
BioMarin's Drug Approved by FDA for PKU Treatment
23h ago
Benzinga
Amicus Therapeutics Q4 Highlights: Revenue Growth Amid Losses
Feb 23 2026
NASDAQ.COM
Amicus Therapeutics Reports FY 2025 Financial Results
Feb 20 2026
seekingalpha
Amicus Therapeutics Reports Q4 Adjusted EPS of $0.10, Exceeding IBES Estimate of $0.09
Feb 20 2026
moomoo
Investor Rights Law Firm Investigates Multiple Companies
Feb 19 2026
Globenewswire
Monteverde Law Firm Investigates RAPT and Others for Shareholder Recovery
Feb 19 2026
Globenewswire
Halper Sadeh LLC Investigates Multiple Companies for Potential Violations
Feb 02 2026
Globenewswire
Warning Signs for Overbought Healthcare Stocks
Feb 02 2026
Benzinga
BioMarin Pharmaceutical Set to Report 2025 Financial Results Soon
Jan 31 2026
Fool
BioMarin Expects Strong Sales for Voxzogo in Q4
Jan 31 2026
NASDAQ.COM
Halper Sadeh Investigates Amicus Therapeutics Sale to BioMarin at $14.50 per Share
Jan 23 2026
Businesswire
Halper Sadeh Investigates Potential Violations by Penumbra, Amicus, DigitalBridge, and Flushing Financial
Jan 22 2026
Globenewswire
Halper Sadeh Investigates TreeHouse Foods' $22.50 Share Sale to Industrial F&B Investments
Jan 08 2026
PRnewswire
Exelixis Collaborates with Natera for STELLAR-316 CRC Study
Jan 08 2026
NASDAQ.COM
Halper Sadeh Investigates EKSO Merger and Other Transactions
Jan 07 2026
Globenewswire
Halper Sadeh Investigates EKSO Merger and Other Transactions
Jan 06 2026
Globenewswire
Show More News
